id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0222-0006,FDA,FDA-2002-D-0222,FDA,Notice,NWL-Notice of Withdrawl,2006-06-01T04:00:00Z,2006,6,2006-05-30T04:00:00Z,,2008-04-12T01:17:30Z,,0,0,0900006480497118
FDA-2002-D-0222-0004,FDA,FDA-2002-D-0222,GUIDANCE,Supporting & Related Material,GDL-Guidance,2003-12-08T05:00:00Z,2003,12,,,2008-04-12T01:17:30Z,,0,0,0900006480497116
FDA-2002-D-0222-0005,FDA,FDA-2002-D-0222,GUIDANCE,Supporting & Related Material,GDL-Guidance,2003-12-08T05:00:00Z,2003,12,,,2008-04-12T01:17:30Z,,0,0,0900006480497117
FDA-2002-D-0222-0003,FDA,FDA-2002-D-0222,FDA,Notice,NAD-Notice of Availability of Data,2003-12-08T05:00:00Z,2003,12,2003-11-20T05:00:00Z,,2008-04-12T01:17:30Z,,0,0,0900006480497115
FDA-2002-D-0222-0001,FDA,FDA-2002-D-0222,FDA,Notice,NAD-Notice of Availability of Data,2002-06-19T04:00:00Z,2002,6,2002-06-19T04:00:00Z,2002-08-21T03:59:59Z,2008-04-12T01:17:30Z,,0,0,09000064804970bd
FDA-2002-D-0222-0002,FDA,FDA-2002-D-0222,Guidance,Supporting & Related Material,GDL-Guidance,2002-06-19T04:00:00Z,2002,6,,,2008-04-12T01:17:30Z,,0,0,09000064804970e7